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Abstract. Glaucoma is a chronic neurodegenerative disease characterized by apoptosis of retinal ganglion
cells and subsequent loss of visual function. Early detection of glaucoma is critical for the prevention of
permanent structural damage and irreversible vision loss. Raman spectroscopy is a technique that provides rapid
biochemical characterization of tissues in a nondestructive and noninvasive fashion. In this study, we explored the
potential of using Raman spectroscopy for detection of glaucomatous changes in vitro. Raman spectroscopic
imaging was conducted on retinal tissues of dogs with hereditary glaucoma and healthy control dogs. The Raman
spectra were subjected to multivariate discriminant analysis with a support vector machine algorithm, and a
classification model was developed to differentiate disease tissues versus healthy tissues. Spectroscopic analysis
of 105 retinal ganglion cells (RGCs) from glaucomatous dogs and 267 RGCs from healthy dogs revealed spectro-
scopic markers that differentiated glaucomatous specimens from healthy controls. Furthermore, the multivariate
discriminant model differentiated healthy samples and glaucomatous samples with good accuracy [healthy 89.5%
and glaucomatous 97.6% for the same breed (Basset Hounds); and healthy 85.0% and glaucomatous 85.5%
for different breeds (Beagles versus Basset Hounds)]. Raman spectroscopic screening can be used for in vitro
detection of glaucomatous changes in retinal tissue with a high specificity. C©2011 Society of Photo-Optical Instrumentation
Engineers (SPIE). [DOI: 10.1117/1.3642010]
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1 Introduction
Glaucoma is an optic neuropathy which is characterized by a
progressive optic nerve head cupping and ultimately vision loss.
It is the second leading cause of blindness worldwide according
to the World Health Organization.1 Glaucoma is characterized
by a progressive death of retinal ganglion cells (RGCs), which
ultimately results in the loss of visual function. Elevated intraoc-
ular pressure (IOP) is considered a primary risk factor for the
progression of glaucomatous neuropathy.1, 2 In many patients,
despite the adequate control of the IOP, the loss of vision con-
tinues to progress, which necessitates further identification of
molecular mechanisms responsible for the glaucomatous neu-
rodegeneration and development of novel diagnostic modalities,
which can detect glaucomatous changes even in patients where
IOP is considered normal.2–5
Raman spectroscopy is a technique that provides rapid char-
acterization of tissue and bodily fluids in a nondestructive and
noninvasive fashion. This methodology relies on inelastic scat-
tering of monochromatic light by macrobiomolecules in the tis-
sue, usually from a laser in the visible or near-infrared range.6
Raman spectroscopy is one of the ideal tools to obtain the general
biochemical landscape of biological samples. In recent years a
marked upsurge in the use of Raman spectroscopy as a nonin-
vasive probing technique has occurred in biomedical research.
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The diverse applications have included characterization of dif-
ferent cancers by obtaining biochemical information from an
in situ sample such as lung cancer,7–9 vitamin distribution in
tissues10, 11 and the investigation of bone properties.12 Once the
Raman spectra of a tissue sample are acquired, mathematical
classification techniques are utilized to differentiate the spectral
signatures of diseased and normal tissues.
In order to better understand glaucomatous changes that oc-
cur in the retina and optic nerve and develop effective diagnostic
and therapeutic modalities for human disease, it is essential to
use animal models that recapitulate the silent and slow devel-
opment of the disease characterized by a progressive loss of a
RGC function. Numerous inducible animal models of glaucoma
have been used successfully to test different therapeutic strate-
gies and to evaluate molecular mechanisms of RGC damage
resulting from chronic elevation of IOP.2, 13, 14 Due to the similar
size to the human eye, spontaneously occurring large animal
models (hereditary canine glaucoma) offer a unique opportu-
nity to obtain functional, structural, and molecular data using
instrumentation identical to that used in human patients.15
The primary purpose of this study was to explore the
potential of using Raman spectroscopy for characterization of
glaucomatous molecular signatures. We compared the Raman
spectral differences between canine glaucomatous eyes and
healthy (control) eyes. The overall objective was to identify
spectroscopic markers associated with glaucomatous changes
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in retinal ganglion cells, and to develop a classification method-
ology which potentially could be effectively used to develop
in vivo imaging modalities for early glaucoma detection using
Raman spectroscopy.
2 Materials and Methods
2.1 Animals and Tissue Collection
All animal studies were conducted in accordance with the ARVO
Statement for Use of Animals in Ophthalmic and Vision Re-
search, and procedures were approved by the Iowa State Uni-
versity Committee on Animal Care (IACUC Grant Nos. 11-
09-6827-K and 9-05-5968-K). Eyes were collected from eight
Basset Hounds with hereditary progressive angle closure glau-
coma from our colony,15 and retinal sections were used for
Raman spectroscopic investigation. Additionally, eyes from 12
adult healthy Beagles and 3 healthy Basset Hounds were used
to serve as a control tissue. All control animals underwent oc-
ular examination (slit lamp biomicroscopy, intraocular pressure
evaluation, indirect ophthalmoscopy, gonioscopy), to rule out
the possible presence of ocular disease before inclusion in the
study.
Eyes were surgically removed from glaucomatous Basset
Hounds once their IOP reached the 35 to 45 mmHg range. At
the time of removal, eyes did not have vision, but had positive
photopic blink response and pupil light reflex responses. Eyes
from control healthy Beagles and healthy Basset Hounds were
collected after euthanasia for reasons not related to this study.
Eyes were fixed in the 10% buffered paraformaldehyde for 24 h
and then rinsed and paraffin imbedded. Twenty micrometer thick
central retinal sections containing optic nerve head profile were
made and placed on gold-aluminum coated histology slides for
the purposes of Raman imaging. Raman spectra were acquired
from the fixed tissue sections using a Raman microscope with
4×, 10×, and 100× objectives.
3 Acquisition of Raman Spectrum from
Retinal Tissues
Raman measurements were performed using a DXR Dispersive
Raman Microscope (Thermo Scientific, Inc., Madison, Wiscon-
sin) with 780 nm, 14 mW excitation laser with 50 μm pinhole
at ambient temperature. Raman spectra were collected with var-
ious exposure times (15, 20, 30, 60, 99 s) from 550 and to
2000 cm− 1 at a resolution of 1 cm− 1.
With the 100× objective, individual RGCs can be resolved
at subcellular spatial resolution (1 to 1.5 μm), and potential
characterization of spectroscopic subcellular compartmentation
within individual RGC can be achieved. However, this study fo-
cused on differentiation of healthy and glaucomatous tissues as
whole units, and subcellular compartmentation was not investi-
gated. Five spectra were collected from each individual cell at
different spots and an average spectrum was then calculated (to
minimize the variation due to subcellular compartmentation) for
that cell to be used as one RGC spectrum in subsequent analy-
sis (105 RGC spectra from glaucomatous Basset Hound tissues,
105 RGC spectra from healthy Basset Hound tissues, and 162
RGC spectra from healthy Beagle tissues, respectively). With
4× and 10× objectives, spectra were collected from the entire
RGC region as a whole (215 spectra from glaucomatous Basset
Hound tissues, 220 spectra from healthy Basset Hound tissues,
and 205 spectra from healthy Beagle tissues, respectively). The
intensity of the Raman spectrum acquired with low magnifi-
cation objectives (4× and 10×) was stronger than that of an
individual RGC cell due to the larger amount of Raman photons
being collected. Nonetheless, their spectroscopic characteristics
(i.e., peak wave numbers and peak profiles) were almost iden-
tical. Lower magnification objectives delivered the laser power
to a much larger area on the tissue samples (∼1 mm2 at 4×),
and resulted in a much smaller laser energy density at the tissue
surface. After normalization, all spectra from the same type of
samples were pooled together for the development and testing
of the discriminant model generated using a support vector ma-
chine (SVM). The total spectra for each type of samples were:
320 from glaucomatous Basset Hound tissues, 325 from healthy
Basset Hound tissues, and 367 from healthy Beagle tissues.
4 Spectral Data Processing
All spectra were baseline corrected and smoothed using a 20-
point averaging algorithm to reduce the baseline variability and
background noises at the region between 550 and 2000 cm− 1.
All spectra were then normalized by setting the intensity of the
strongest Raman peak (amide I) to unity. All data processing was
conducted using Omnic professional Software Suite (Thermo
Scientific, Inc., Madison, Wisconsin).
A standardized residual spectrum (SRS) was then calculated
from the original spectral data using Eq. (1).
SRS(raman shift) = X (raman shift) −
¯X (raman shift)
s.d.(raman shift) , (1)
where SRS is the standardized residual spectral intensity at each
Raman shift wavenumber, X is the Raman intensity of each indi-
vidual spectrum at the same Raman shift, ¯X is the mean Raman
intensity of all spectra from the same data set (i.e., diseased or
control) at the same Raman shift, and s.d. is the standard devia-
tion of the Raman intensity within the data set at the same Raman
shift. The SRS highlights the variations in spectral data measured
from the same type of samples (i.e., control versus diseased),
and they were used in a subsequent discriminant analysis.
It should be noted that the chemical fixation with
paraformaldehyde alters the chemical makeup of the tissues
and changes the Raman spectroscopic characteristics of the tis-
sue samples. However, it has been demonstrated that fixation
with paraformaldehyde produces spectral content that is clos-
est to that of living cells.16 Using hierarchical cluster analysis
and principal components analysis (PCA) on individual Raman
spectra randomly selected form the nuclear regions of single
cancer cells, Draux and co-workers have shown that formalin-
fixation and cytocentrifugation are sample preparation methods
that have little impact on the biochemical information as com-
pared to living conditions.17 Although the chemical fixation is
a possible confounding variable in the differentiation and clas-
sification analysis of the spectra acquired from the normal and
diseased eye samples, its impact on the analysis is limited in na-
ture since all samples were processed under identical conditions.
5 PCA and Data Compression for SVM
Discriminant Modeling
For discriminant analysis, as the dimensions of the data set
(i.e., each wave number in the spectral data represents an
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independent dimension) become large, the limitation on the
capability of detecting distinguishable classes becomes severe.18
PCA was used in this study for the dimensionality reduction.
The data sets (SRS) were compressed into PC scores, and 10 to
50 PC scores (accounted for 94% to 99% of the total variance
in the data sets, as shown in Fig. 6) were selected from 1506
dimensional hyperspectral data as inputs for multivariate dis-
criminant classification model generated using a Support Vector
Machine (Ref. 19) implemented with MATLAB SVM toolbox
(The Mathworks, Inc., Natick, Massachusetts) using polynomial
kernel function.20 Training sets (110 spectra from each group,
330 in total) and testing sets (100 spectra/tests) were randomly
chosen from the measured spectra [from glaucomatous Bas-
set Hounds (diseased), healthy Basset Hounds (control 1), and
healthy Beagles (control 2)]. Average classification accuracy
was calculated from 10 random replications of the discriminant
process.
6 Results
6.1 Spectroscopic Characterization of Retinal
Ganglion Cells from the Retinal Tissues
The optical images of the retinal tissue sections of glaucomatous
Basset Hound, healthy Hasset Hound, and healthy Beagle are
shown in Fig. 1. The layers of RGCs were identified under the
microscope, as shown in the figures.
Raman peaks are represented by their wave number (Raman
shift) and intensity. The peak intensities are dependent on
many factors that may vary from sample to sample (i.e.,
sample size, exposure time, etc.), but their Raman shift remains
identical as long as the molecular makeup is the same. A typical
Raman spectra and SRS measured from glaucomatous Basset
Hound RGCs are shown in Fig. 2 in the 550 to 2000 cm− 1
range. From the spectra, we could identify contributions from
functional groups of the major macromolecules presented in the
cells. Proteins (i.e., amide I and III peaks, phenylalanine peaks,
tryptophan peaks, tyrosine peaks) and DNAs (i.e., adenine peak,
thymine peaks) can both be characterized with specific Raman
bands. The differences shown by these Raman signature bands
can be used to differentiate diseased tissues from healthy ones.
To compare the biochemical changes between RGCs of glau-
comatous Basset Hounds and healthy dogs (Beagles and Basset
Hounds), represented by their Raman spectroscopic signatures,
we measured Raman spectra from 105 RGCs from 8 glaucoma-
tous Basset Hounds, 105 RGCs from 3 healthy Basset Hounds,
and 162 RGCs from 12 healthy Beagles with normal vision.
The average and difference spectra between healthy and glau-
comatous dogs are shown in Fig. 3. The difference spectrum
was acquired by subtracting the control (healthy Beagle and
healthy Basset Hound) from the diseased (glaucomatous Basset
Hound) spectra, respectively. The wave number and intensity
changes in those Raman bands of biological importance were
indicative of changes in the secondary structure and variations
in local environments of intracellular proteins as well as DNAs,
which may determine the characteristics of glaucomatous tis-
sues. Differences at amide III peaks illustrate the changes in
the overall concentration of total proteins,21 the composition of
proteins also shows some significant differences, as evidenced
by Raman bands of various amino acids, at 800 to 1200 cm− 1.
These changes can potentially be used as spectroscopic markers
for the detection of glaucoma.
7 Discriminant Classification of Glaucomatous
Versus Healthy Spectra Using Support Vector
Machine
A SVM was utilized to generate discriminant classification mod-
els to classify a measured spectrum from a retinal tissue sample
into the two categories (glaucomatous and normal). One hun-
dred and ten spectra measured from the control group (healthy
Beagles and healthy Basset Hounds) and 110 spectra measured
from the glaucomatous group (glaucomatous Basset Hounds)
were used as the training data sets to create the SVM discrimi-
nant models. After compressing the original spectral data using
PCA, the resulted PC scores were used to calculate hyperdi-
mensional classifier. The classification model generated with
10 PC scores (10 D hyperdimensional classifier) is illustrated in
Fig. 4. The support vectors defined a hyperplane that divided the
10 D hyperspace into two domains: normal and glaucomatous.
The classification model was then validated through random
testing of 10 testing data sets, each containing 100 spectra
measured from the control and glaucomatous retinal tissues,
respectively. The average classification accuracy was then cal-
culated to evaluate the performance of the classification models.
8 Effect of Spectral Data Processing for the
Classification Accuracy
Using PCA, the dimensionality of the spectral data was greatly
reduced. With 50 PCs, over 99% of the total variance within
spectral data measured for each type of sample could be ex-
plained. Ten PCs accounted for 94% of the total variance for
each type of samples. Figure 5 shows the impact of the number
Fig. 1 Optic images of retinal tissue sections from a healthy Beagle (a), a healthy Basset Hound (b), and glaucomatous Basset Hounds (c) on gold
coated slides (RGC–retinal ganglion cell layer).
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Fig. 2 Typical Raman spectrum and SRS of RGCs from glaucomatous Basset Hounds.
of PCs used in the SVM discriminant model on the classification
accuracy for healthy Basset Hounds (control) and glaucomatous
Basset Hounds (diseased). Consistently, classification accuracy
for glaucomatous RGCs was better than that for normal RGCs.
We hypothesize that biochemical changes caused by glaucoma
may introduce characteristic spectroscopic signatures that lead
to more coherently intercorrelated clustering of the data rep-
resenting glaucomatous RGCs in the hyperspace of the SVM
classifier, which results in the better classification accuracy.
As the number of PCs increased from 10 to 30, the clas-
sification accuracy for a glaucomatous Basset Hound reached
100%. Since the number of spectra used in training the dis-
criminant model (220) is far larger than the number of PC
scores (<50), it is reasonable to believe that the high clas-
sification accuracy is not caused by overfitting.22 Given the
fact that the glaucomatous Basset Hounds investigated in this
study were at the late stage of the disease and have lost al-
most 100% vision loss, it could be reasoned that severe physi-
ological changes have occurred in their RGCs, which may re-
sult from significant biochemical alterations to the cells that
are captured in their Raman spectral data. Interestingly, the
classification accuracy for healthy Basset Hounds peaked at
30 PCs (∼91%) and slightly declined with more PCs being used
in the discriminant model, suggesting that further optimization
is possible by identifying the PCs that are the most respon-
sible for differentiating the diseased group from the healthy
group.
9 Classification Differences between Different
Breeds of Dogs
Hereditary glaucoma is a genetic disorder affecting RGCs. It is
reasonable to hypothesize that the biochemical makeup of the
RGCs in diseased Basset Hounds differs from that of healthy
Basset Hounds. As demonstrated by the high accuracy of the
classification results reported before, these intrinsic biochem-
ical differences were captured by their Raman spectroscopic
characteristics.
We have previously demonstrated that the gene and protein
expression in the retina of glaucomatous and healthy dogs are not
breed related, but it rather depends on the stage of glaucoma.23
Therefore, a valid question to ask is whether or not the spec-
troscopic differences between healthy and glaucomatous retinal
tissue exist regardless of the breeds of the dogs. To answer this
question, we have compared Raman spectroscopic data between
spectral specimens of two healthy control populations (healthy
Basset Hounds and healthy Beagles).
The classification results to differentiate glaucomatous
Basset Hounds and healthy Beagles are shown in Fig. 6 and
Table 1. A slight reduction in classification accuracy was ob-
served. With 10 PCs, 85.0% of RGCs were correctly classified
for the healthy (control) group, and 85.5% RGCs were correctly
classified for the glaucomatous group. When classification
accuracy was compared within the same breed (control healthy
Basset Hounds and glaucomatous Basset Hounds), 89.5%
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Fig. 3 Average Raman spectra and Difference spectra between glaucomatous and normal RGCs: (a) Healthy Basset Hounds versus glaucomatous
Basset Hounds; (b) Healthy Beagles versus glaucomatous Basset Hounds. 1. Glaucomatous Basset Hound; 2. Healthy Basset Hound; 3. Difference
spectrum (2). Healthy Beagle; (3). Difference spectrum.
Fig. 4 An example of the trained classifier by the support vector machine. The trained classifier between the spectra from RGCs from control healthy
Basset Hounds (black) and glaucomatous Basset Hounds (gray) is shown. It should be noticed that this is a two-dimensional projection of a 10-D
hyperplane separation, thus some overlapping was observed between the two groups while in 10-D space they were well separated. The SVM
separating function divided the space into two areas represented by different colors (black and gray). The “circled” dots are support vectors.
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Fig. 5 The influence of the number of PC scores used in SVM discriminant models on the differentiation accuracy of classifying tissues into healthy
and glaucomatous categories. Each error bar indicates the standard deviation of classification accuracy from 10 replications of different training and
testing data sets. The inlet shows the total variance acocunted for by the number of different PC scores.
Fig. 6 Classification performance of the SVM model to differentiate healthy tissues from glaucomatous tissues. Each error bar indicates the standard
deviation of classification accuracy from 10 replications with different training and testing data sets.
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Table 1 The average classification accuracies for retinal ganglion cells between control and diseased tissues using 10 PCs in SVM discriminant
analysis.
Healthy Basset Hounds versus Healthy Beagle versus
glaucomatous Basset Hounds glaucomatous Basset Hounds
Normal RGCs Glaucomatous RGCs Normal RGCs Glaucomatous RGCs
Classified as Normal 89.5% 97.6% 85.0% 85.5%
Classified as Glaucomatous 10.5% 2.4% 15% 14.5%
RGCs were correctly classified for the healthy group, and
97.6% were correctly classified for the glaucomatous group.
These results strongly suggest that there are significant bio-
chemical differences between the retinal ganglion cells of glau-
comatous and healthy dogs that can be identified from their Ra-
man spectra, even between different breeds of dogs. The slight
reduction in classification accuracy between different breeds
may be related to the interbreed genetic discrepancy, which may
result in a greater spread of the data points, and may lead to the
mild reduction in the classification accuracy.
The hereditary glaucoma in Basset Hounds is most likely
a result of genetic mutation(s) in the ocular tissues, and po-
tentially all cells in the body. The classification results using
the Raman spectra of fibroblast cells and retinal ganglion cells
extracted from the control (healthy Beagles) and glaucomatous
animals (Basset Hounds) are shown in Fig. 7 and Table 2. A dra-
matic reduction in classification accuracy was observed. Only
69.2% of fibroblasts were correctly classified for the healthy
group, and only 46% of fibroblasts were correctly classified
for the glaucomatous group. These observations suggested that
the spectroscopic differences between healthy and glaucoma-
tous animals are probably tissue type specific: they could only
be observed with high certainty in RGCs, but not in fibrob-
last cells. The possible explanation for observed changes is
that the biochemical footprints associated with glaucoma could
be the result of the possible genetic abnormality resulting in
a disease phenotype only in ocular tissues. However, it can-
not be excluded that the presence of more aggressive disease
phenotype in affected eyes (elevated intraocular pressure, neu-
roinflammatory changes, neuronal death, etc.) resulted in more
prominent biochemical changes providing a distinct spectro-
scopic pattern.
10 Discussion
Glaucoma is a disease which affects millions of patients world-
wide, and frequently is diagnosed only when significant optic
nerve damage has already developed. For the purposes of this
study we have intentionally used tissues from animals with the
advanced hereditary glaucoma to make sure that observed spec-
troscopic changes present in glaucomatous eyes can be detected.
For this technology to become a viable clinical tool, it is obvious
that testing needs to be done in animals at a very early stage of
the disease, which would be more representative of the condition
seen in early glaucoma human patients and glaucoma disease
suspects who are in the strongest need of accurate and early
diagnosis.
In this study, support vector machine discriminant classifi-
cation modeling was incorporated with Raman spectroscopy to
differentiate and classify differences between glaucomatous and
healthy (control) RGCs. It was demonstrated that Raman imag-
ing of RGC chemical profiles results in the high recognition
accuracy of the tissue status (91% of healthy RGCs and 100%
of glaucomatous RGCs were classified correctly by a predic-
tive model which was trained using defined glaucomatous and
healthy control samples). Furthermore, Raman spectroscopic
signatures associated with changes in intracellular protein com-
positions were identified, which potentially can be used as spec-
troscopic biomarkers for glaucoma diagnosis in vivo in the fu-
ture. To date, Raman spectroscopy has not been fully explored
to detect molecular changes in eye tissues associated with glau-
coma.
For the 780 nm diode laser that was used in this study, the
threshold limit value (TLV) can be calculated as follows,24, 25
where CA is the correction factor for different wavelength:
TLV = 1.8×100.002×(λ−700)×t−1/4mw/cm2. (2)
The TLV determines the maximum permissible energy ex-
posure to the retina in an in vivo measurement. In the current
study, with 15 and 99 s exposure time, the TLV is 1.32 and
0.82 mW/cm2, respectively. The laser spot-size on the sam-
ple was ∼1 mm2 with 4× objective, and ∼10% laser power
(1.4 mW) was delivered on the sample. The resulting power den-
sity on the sample was 140 mW/cm2, significantly higher than
the TLV. To utilize Raman spectroscopy for in vivo imaging, the
laser power density on the retina has to be greatly reduced.
Fig. 7 Classification accuracy for RGCs and fibroblast cells from glau-
comatous Basset Hounds (glaucomatous) and healthy Beagles (normal).
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Table 2 The average classification accuracies for retinal ganglion cells and fibroblast cells between normal Beagle and glaucomatous Basset
Hounds using 10 PCs in SVM discriminant analysis.
RGCs Skin fibroblasts
Normal (Beagles) Glaucomatous (Basset Hounds) Normal (Beagles) Glaucomatous (Basset Hounds)
Classified as Normal 85.0% 85.5% 69.2% 54.0%
Classified as Glaucomatous 15.0% 14.5% 30.8% 46.0%
Raman scattering is a weak phenomenon in comparison
to autofluorescence coming mostly from protein molecules,26
Raman spectral fingerprints can be overwhelmed by stronger
fluorescence background when in vivo imaging is conducted.
Earlier reports utilizing Raman spectroscopy for ophthalmo-
logical investigation focused on detection of human macular
pigment and glutamate in the eyes, in which the excitation laser
wavelength was selected to resonate with the vibrational modes
of the pigment/glutamate molecules, and an enhanced Raman
signal was achieved.25, 27 To acquire a Raman signal directly
from the RGC cells without the resonance enhancement effects,
the autofluorescence background has to be removed before
the analysis of the vibrational bands takes place. The most
common methods for background removal, as the one currently
used in this study, are based on digital signal subtraction
utilizing the common feature of fluorescent backgrounds—a
smooth function of the emission wavelength.28, 29 Assuming
the fluorescence signal contributes F photons to the recorded
signal, while Raman signal adds an additional R photons (for
a typical experimental setting RF),the shot noise introduced
by the signal in this case was calculated as N = (F + R)1/2
≈ F1/2, resulting in a signal-to-noise ratio (SNR) equal to R/F1/2
after the fluorescent background has been digitally subtracted
from the data. This level of noise is still worse than the ideal
SNR in the absence of the fluorescent background, which can
be defined as SNRideal = R1/2. From the above equations, it is
evident that the SNR degrades by a factor of (F/R)1/2, and in
order to compensate for it, the data acquisition times of roughly
equal to or longer than F/R are required. In other words, if the
fluorescent background is somehow reduced by a factor of 1000,
the acquisition times to achieve the same SNR Raman spectra
should also be cut by approximately a factor of 1000 (assuming
that the shot noise is a predominant source of the data noise).
If the acquisition time (exposure time) can be significantly
reduced, the higher laser power can be potentially used to obtain
a higher-quality spectral signal without reaching the safety limit.
One possible solution to overcome excessive retinal expo-
sure to the high levels of laser energy is to utilize pulse laser
with extreme short time-gated detection (10− 12 s). With such
short exposure and detection time, background fluorescence is
eliminated (shorter than the fluorescence lifetime so that fluo-
rescence is not developed), and the signal-to-noise ratio of the
Raman spectral measurement can be significantly improved, al-
lowing much weaker Raman signals to be detectable.30, 31 An
extremely short detection time also allows a much higher laser
power to be applied without increasing the overall retinal laser
energy exposure. Simple calculation reveals that at 10− 12 ex-
posure time, the TLV is 2601 mW/cm2, which is much higher
compared to the energy levels used in this study.
In this study, we have demonstrated that Raman imaging can
be effectively used for the classification of neuronal changes
associated with glaucoma. Further refinement of Raman imag-
ing instrumentation and detection algorithms may provide an
exciting opportunity for development of the novel and sensitive
diagnostic modalities for the early detection of glaucoma.
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